Search

everythinglearnresearchcommunity

for

Search:↓

Over 40% of postmenopausal women experience hair loss, with treatments aiming to stop further loss and possibly thicken hair.

People with alopecia have a higher risk of thyroid cancer.

Chemotherapy can cause skin issues and hair loss, and this guide explains how to manage them.

WNT7A gene expression is higher in early stages of androgenetic alopecia, showing the role of WNT pathway, apoptosis, and inflammation in the disorder.

The document concludes that various drugs for men's health issues are in development, with treatments for sexual dysfunction and prostate conditions being the most advanced.

Adult female acne treatment should be personalized, considering individual preferences and pregnancy, using various topical and oral medications while managing side effects and resistance.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Cilostazol helps hair grow by making hair root cells grow faster and changing growth factor levels.

Hair growth is influenced by interactions between skin layers, growth factors, and hormones, but the exact mechanisms are not fully understood.

Some medications can cause hair loss, but stopping the drug usually leads to recovery within 3 months.

EGFR inhibitors can cause various skin issues during cancer treatment, and managing these is important for patient care.

EGFR inhibitors often cause skin problems and other side effects, but these are usually reversible and can be managed to keep patients comfortable.

Skin problems like acne, dry skin, and nail and hair changes are common in patients taking EGFR inhibitors.

The mTOR signaling pathway is crucial for hair health and targeting it may lead to new hair loss treatments.

The conclusion is that Fgf18 and Tgf-ß signaling could be targeted for hair loss treatments.

Intermittent isotretinoin can cause various skin, hair, and nail changes.

EGFR-TKIs can cause significant skin, nail, and organ side effects.

A man's severe skin reaction from cancer treatment improved with early diagnosis and proper medication.

The document concludes that changes in eyelashes and eyelid skin can indicate various local and systemic diseases.

PRIDE syndrome includes skin and hair issues from cancer treatment with EGFR inhibitors.

Ruxolitinib treatment led to unexpected hair regrowth in a patient with alopecia universalis.

A cancer drug caused unusual hair growth on a 100-year-old man's scalp and eyelashes.

Matriptase is highly active in hair follicles and sebaceous glands, especially during hair growth phases.

Blocking COX, especially COX-2, in the skin can reduce inflammation and pain and may help prevent skin cancer.

Lasers can help reduce skin side effects from cancer treatment.

A plant mixture extract helped grow hair by boosting cell growth and growth factors while blocking a hair loss-related enzyme.

Estrogen can temporarily slow down hair growth but this can be reversed.

Herbal products might promote hair growth with fewer side effects, but more research is needed to confirm their safety and effectiveness.

Rabbit skin analysis showed changes in hair growth and identified miRNAs that may regulate hair follicle development.

Chemotherapy often causes temporary hair loss, which is distressing and needs better treatment and support.